FAAH Availability in Psychiatric Disorders: A PET Study
Mental Health & Behavioral Research
What is the purpose of this trial?
The aim of the present study is to examine Fatty Acid Amide Hydrolase (FAAH) availability in humans, including healthy individuals and across a spectrum of psychiatric disorders in which alterations in the endocannabinoid system are observed.
- Ages18 years - 65 years
- Trial withYale University School of Medicine
- Start Date05/28/2020
- End Date08/01/2023
- Last Updated11/17/2021
- Study HIC#2000027585